首页> JAMA ophthalmology> Orthokeratology, 0.04% Atropine, and 0.01% Atropine for Myopia Control: A Randomized Clinical Trial.

Orthokeratology, 0.04% Atropine, and 0.01% Atropine for Myopia Control: A Randomized Clinical Trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hannan,Xu

第一单位： Department of Preventative Ophthalmology, Shanghai Eye Diseases Prevention & Treatment Center/Shanghai Eye Hospital, National Clinical Research Center for Eye Diseases, Shanghai Engineering Research Center of Precise Diagnosis and Treatment of Eye Diseases, School of Medicine, Tongji University, Shanghai, China.;Department of Ophthalmology, Shanghai General Hospital, Shanghai Clinical Research Center for Eye Diseases, Shanghai Key Clinical Specialty, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

作者： Hannan,Xu ^[1] ; Moxin,Chen ^[2] ; Luyao,Ye ^[3] ; Qin,Shu ^[2] ; Yajun,Peng ^[4] ; Xiaoyi,Liang ^[2] ; Tao,Yu ^[4] ; Yongrong,Ji ^[2] ; Shanshan,Li ^[4] ; Qin,Shen ^[2] ; Jiangnan,He ^[4] ; Lin,Li ^[2] ; Jianfeng,Zhu ^[5] ; Xun,Xu ^[1]

作者单位： Department of Preventative Ophthalmology, Shanghai Eye Diseases Prevention & Treatment Center/Shanghai Eye Hospital, National Clinical Research Center for Eye Diseases, Shanghai Engineering Research Center of Precise Diagnosis and Treatment of Eye Diseases, School of Medicine, Tongji University, Shanghai, China.;Department of Ophthalmology, Shanghai General Hospital, Shanghai Clinical Research Center for Eye Diseases, Shanghai Key Clinical Specialty, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[1] Department of Ophthalmology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.;Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China. ^[2] Department of Ophthalmology, The Affiliated People's Hospital of Ningbo University, The Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China. ^[3] Department of Ophthalmology, Shanghai General Hospital, Shanghai Clinical Research Center for Eye Diseases, Shanghai Key Clinical Specialty, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[4] Department of Preventative Ophthalmology, Shanghai Eye Diseases Prevention & Treatment Center/Shanghai Eye Hospital, National Clinical Research Center for Eye Diseases, Shanghai Engineering Research Center of Precise Diagnosis and Treatment of Eye Diseases, School of Medicine, Tongji University, Shanghai, China. ^[5]

DOI 10.1001/jamaophthalmol.2025.2321

PMID 40705323

发布时间 2025-07-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAMA ophthalmology

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

检索历史清除

Orthokeratology, 0.04% Atropine, and 0.01% Atropine for Myopia Control: A Randomized Clinical Trial.

JAMA ophthalmology

相似文献

同项目论文

JAMA ophthalmology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Orthokeratology, 0.04% Atropine, and 0.01% Atropine for Myopia Control: A Randomized Clinical Trial.

JAMA ophthalmology

相似文献

同项目论文

JAMA ophthalmology

相关期刊

检索历史清除